FWIW - SLXP target reduced yesterday by Sun Trust Robinson to $25.00. Xifaxin sales (mainstay drug) reduced as well. Second firm to bring this up now as an issue. Company came out and reaffirmed earnings after it was brought up the first time. Who to believe? Chart wise, had to go back to last Jan. to find another support level and see $14 - $14.25. Watching it.